Literature DB >> 26854535

Rapid Optimization of Mcl-1 Inhibitors using Stapled Peptide Libraries Including Non-Natural Side Chains.

Raheleh Rezaei Araghi1, Jeremy A Ryan2, Anthony Letai2,3, Amy E Keating1,4.   

Abstract

Alpha helices form a critical part of the binding interface for many protein-protein interactions, and chemically stabilized synthetic helical peptides can be effective inhibitors of such helix-mediated complexes. In particular, hydrocarbon stapling of peptides to generate constrained helices can improve binding affinity and other peptide properties, but determining the best stapled peptide variant often requires laborious trial and error. Here, we describe the rapid discovery and optimization of a stapled-helix peptide that binds to Mcl-1, an antiapoptotic protein that is overexpressed in many chemoresistant cancers. To accelerate discovery, we developed a peptide library synthesis and screening scheme capable of identifying subtle affinity differences among Mcl-1-binding stapled peptides. We used our method to sample combinations of non-natural amino-acid substitutions that we introduced into Mcl-1 inhibitors in the context of a fixed helix-stabilizing hydrocarbon staple that increased peptide helical content and reduced proteolysis. Peptides discovered in our screen contained surprising substitutions at sites that are conserved in natural binding partners. Library-identified peptide M3d is the most potent molecule yet tested for selectively triggering mitochondrial permeabilization in Mcl-1 dependent cell lines. Our library approach for optimizing helical peptide inhibitors can be readily applied to the study of other biomedically important targets.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26854535      PMCID: PMC4874891          DOI: 10.1021/acschembio.5b01002

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  53 in total

Review 1.  Small-molecule inhibitors of protein-protein interactions: progressing towards the dream.

Authors:  Michelle R Arkin; James A Wells
Journal:  Nat Rev Drug Discov       Date:  2004-04       Impact factor: 84.694

2.  Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics.

Authors:  Anthony Letai; Michael C Bassik; Loren D Walensky; Mia D Sorcinelli; Solly Weiler; Stanley J Korsmeyer
Journal:  Cancer Cell       Date:  2002-09       Impact factor: 31.743

3.  Reactivation of the p53 tumor suppressor pathway by a stapled p53 peptide.

Authors:  Federico Bernal; Andrew F Tyler; Stanley J Korsmeyer; Loren D Walensky; Gregory L Verdine
Journal:  J Am Chem Soc       Date:  2007-02-07       Impact factor: 15.419

Review 4.  Peptide stapling techniques based on different macrocyclisation chemistries.

Authors:  Yu Heng Lau; Peterson de Andrade; Yuteng Wu; David R Spring
Journal:  Chem Soc Rev       Date:  2014-09-08       Impact factor: 54.564

5.  SORTCERY-A High-Throughput Method to Affinity Rank Peptide Ligands.

Authors:  Lothar Luther Reich; Sanjib Dutta; Amy E Keating
Journal:  J Mol Biol       Date:  2014-10-12       Impact factor: 5.469

6.  Myeloid cell leukemia-1 inversely correlates with glycogen synthase kinase-3beta activity and associates with poor prognosis in human breast cancer.

Authors:  Qingqing Ding; Xianghuo He; Weiya Xia; Jung-Mao Hsu; Chun-Te Chen; Long-Yuan Li; Dung-Fang Lee; Jer-Yen Yang; Xiaoming Xie; Jaw-Ching Liu; Mien-Chie Hung
Journal:  Cancer Res       Date:  2007-05-10       Impact factor: 12.701

7.  The (i, i + 4) Phe-His interaction studied in an alanine-based alpha-helix.

Authors:  K M Armstrong; R Fairman; R L Baldwin
Journal:  J Mol Biol       Date:  1993-03-05       Impact factor: 5.469

8.  Hydrophile scanning as a complement to alanine scanning for exploring and manipulating protein-protein recognition: application to the Bim BH3 domain.

Authors:  Melissa D Boersma; Jack D Sadowsky; York A Tomita; Samuel H Gellman
Journal:  Protein Sci       Date:  2008-05-08       Impact factor: 6.725

9.  Cyclic peptide inhibitors of HIV-1 capsid-human lysyl-tRNA synthetase interaction.

Authors:  Varun Dewan; Tao Liu; Kuan-Ming Chen; Ziqing Qian; Yong Xiao; Lawrence Kleiman; Kiran V Mahasenan; Chenglong Li; Hiroshi Matsuo; Dehua Pei; Karin Musier-Forsyth
Journal:  ACS Chem Biol       Date:  2012-02-13       Impact factor: 5.100

10.  Designed BH3 peptides with high affinity and specificity for targeting Mcl-1 in cells.

Authors:  Glenna Wink Foight; Jeremy A Ryan; Stefano V Gullá; Anthony Letai; Amy E Keating
Journal:  ACS Chem Biol       Date:  2014-07-23       Impact factor: 5.100

View more
  12 in total

1.  A new strategy for the in vitro selection of stapled peptide inhibitors by mRNA display.

Authors:  Emil S Iqbal; Stacie L Richardson; Nicolas A Abrigo; Kara K Dods; H Estheban Osorio Franco; Heather S Gerrish; Hari Kiran Kotapati; Iain M Morgan; Douglas S Masterson; Matthew C T Hartman
Journal:  Chem Commun (Camb)       Date:  2019-07-10       Impact factor: 6.222

2.  Iterative optimization yields Mcl-1-targeting stapled peptides with selective cytotoxicity to Mcl-1-dependent cancer cells.

Authors:  Raheleh Rezaei Araghi; Gregory H Bird; Jeremy A Ryan; Justin M Jenson; Marina Godes; Jonathan R Pritz; Robert A Grant; Anthony Letai; Loren D Walensky; Amy E Keating
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-16       Impact factor: 11.205

Review 3.  Engineered protein scaffolds as leads for synthetic inhibitors of protein-protein interactions.

Authors:  Michael G Wuo; Paramjit S Arora
Journal:  Curr Opin Chem Biol       Date:  2018-05-24       Impact factor: 8.822

Review 4.  Targeting intracellular protein-protein interactions with cell-permeable cyclic peptides.

Authors:  Ziqing Qian; Patrick G Dougherty; Dehua Pei
Journal:  Curr Opin Chem Biol       Date:  2017-04-04       Impact factor: 8.822

5.  Enriching Peptide Libraries for Binding Affinity and Specificity Through Computationally Directed Library Design.

Authors:  Glenna Wink Foight; T Scott Chen; Daniel Richman; Amy E Keating
Journal:  Methods Mol Biol       Date:  2017

6.  Differential Effects of β3 - versus β2 -Amino Acid Residues on the Helicity and Recognition Properties of Bim BH3-Derived α/β-Peptides.

Authors:  Geoffrey A Eddinger; Samuel H Gellman
Journal:  Angew Chem Int Ed Engl       Date:  2018-09-20       Impact factor: 15.336

7.  Epistatic mutations in PUMA BH3 drive an alternate binding mode to potently and selectively inhibit anti-apoptotic Bfl-1.

Authors:  Justin M Jenson; Jeremy A Ryan; Robert A Grant; Anthony Letai; Amy E Keating
Journal:  Elife       Date:  2017-06-08       Impact factor: 8.140

8.  IKKγ-Mimetic Peptides Block the Resistance to Apoptosis Associated with Kaposi's Sarcoma-Associated Herpesvirus Infection.

Authors:  Louise C Briggs; A W Edith Chan; Christopher A Davis; Nicholas Whitelock; Hajira A Hotiana; Mehdi Baratchian; Claire Bagnéris; David L Selwood; Mary K Collins; Tracey E Barrett
Journal:  J Virol       Date:  2017-11-14       Impact factor: 5.103

9.  Targeting MUC1-C suppresses BCL2A1 in triple-negative breast cancer.

Authors:  Masayuki Hiraki; Takahiro Maeda; Neha Mehrotra; Caining Jin; Maroof Alam; Audrey Bouillez; Tsuyoshi Hata; Ashujit Tagde; Amy Keating; Surender Kharbanda; Harpal Singh; Donald Kufe
Journal:  Signal Transduct Target Ther       Date:  2018-05-12

10.  Structure-Based Design of Non-natural Macrocyclic Peptides That Inhibit Protein-Protein Interactions.

Authors:  Dennis M Krüger; Adrian Glas; David Bier; Nicole Pospiech; Kerstin Wallraven; Laura Dietrich; Christian Ottmann; Oliver Koch; Sven Hennig; Tom N Grossmann
Journal:  J Med Chem       Date:  2017-10-27       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.